Csenge Advisory Group
REGN icon

Csenge Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Csenge Advisory Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$237K Buy
+312
New +$236K 0.01% 665
2025
Q1 		– Sell
-387
Closed -$276K – 733
2024
Q4 		$276K Sell
387
-76
-16% -$63.8K 0.02% 568
2024
Q3 		$470K Buy
463
+41
+10% +$45.6K 0.02% 435
2024
Q2 		$444K Sell
422
-27
-6% -$26.2K 0.03% 432
2024
Q1 		$432K Buy
449
+49
+12% +$46.6K 0.02% 467
2023
Q4 		$351K Buy
400
+107
+37% +$88.1K 0.02% 488
2023
Q3 		$241K Buy
+293
New +$230K 0.02% 540
2023
Q2 		– Sell
-264
Closed -$217K – 691
2023
Q1 		$217K Sell
264
-14
-5% -$10.6K 0.02% 539
2022
Q4 		$201K Buy
+278
New +$205K 0.02% 561
2022
Q2 		– Sell
-302
Closed -$211K – 654
2022
Q1 		$211K Buy
+302
New +$191K 0.02% 593
2021
Q1 		– Sell
-417
Closed -$201K – 517
2020
Q4 		$201K Sell
417
-774
-65% -$418K 0.02% 411
2020
Q3 		$693K Buy
1,191
+3
+0.3% +$1.82K 0.1% 172
2020
Q2 		$741K Buy
1,188
+546
+85% +$310K 0.11% 144
2020
Q1 		$313K Buy
+642
New +$265K 0.08% 207
2018
Q4 		– Sell
-3
Closed -$1K – 1183
2018
Q3 		$1K Buy
+3
New +$1.14K ﹤0.01% 911

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Csenge Advisory Group's REGN Position: Q3 2026 in Review

Csenge Advisory Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 312 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #665 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in REGN as recently as Q4 2024.

Csenge Advisory Group first reported a position in REGN in Q3 2018 and has held it in 15 quarters since. The position peaked at $741K in Q2 2020. 755 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Csenge Advisory Group held 312 shares of Regeneron Pharmaceuticals worth $237K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Csenge Advisory Group position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Csenge Advisory Group's portfolio in Q3 2026, its #665 holding.
  • Csenge Advisory Group first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 15 quarters since.
  • Csenge Advisory Group's Regeneron Pharmaceuticals position peaked at $741K in Q2 2020.
  • 755 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Csenge Advisory Group's 13F filing for Q3 2026, filed 4 Nov 2026.